E P Damron, J McDonald, P Das, E J Koay, A C Koong, E B Ludmir, S S Noticewala, G L Smith, C M Taniguchi, C Messick, G Chang, B D Minsky, V K Morris, E Holliday
PURPOSE/OBJECTIVE(S): Initial treatment for patients with squamous cell carcinoma of the anal canal includes definitive chemoradiation. Salvage abdominoperineal resection (APR) is the treatment of choice for recurrent or persistent disease. Older studies suggest approximately 50% successful salvage of recurrent or persistent disease with APR. Risk factors for failure after salvage APR are incompletely characterized. MATERIALS/METHODS: Using a single institutional database, patients were identified who underwent salvage APR after definitive intensity-modulated radiotherapy-based chemoradiation between 2003 and 2022...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics